Author:
Marra Alexandre R.,Edmond Michael B.,Ford Bradley A.,Herwaldt Loreen A.,Algwizani Abdullah R.,Diekema Daniel J.
Abstract
Using an algorithm including both enzyme immunoassay (EIA) and nucleic acid amplification (NAAT) for Clostridium difficile infection (CDI) diagnosis, we found that the use of NAAT versus EIA almost doubled our hospital-onset CDI laboratory-identified (LabID) event standardized infection ratio (SIR). We recommend that the current risk adjustment approach be modified.Infect Control Hosp Epidemiol 2016:1–3
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference13 articles.
1. Public Reporting of Health Care–Associated Surveillance Data: Recommendations From the Healthcare Infection Control Practices Advisory Committee
2. Impact of Change to Molecular Testing for Clostridium difficile Infection on Healthcare Facility–Associated Incidence Rates
3. Healthcare-Associated Infections Progress Report. Centers for Disease Control and Prevention website. http://www.cdc.gov/hai/surveillance/progress-report/. Updated 2016. Accessed April 12, 2016.
4. National Healthcare Safety Network. Multidrug-resistant organism and Clostridium difficile infection (MDRO/CDI) module. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/ltach/cdiff-mrsa/index.html. Published 2009. Accessed April 12, 2015.
5. Hospital Compare. Centers for Medicare and Medicaid Services website. https://www.medicare.gov/hospitalcompare/search.html. Updated 2016. Accessed April 12, 2016.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献